SPONSOR
Gilead Sciences
Total Trials
6
Recruiting
6
Phases
Phase 1, Phase 2, Phase 1, Phase 2
Conditions studied: Advanced Solid TumorsHNSCCSCLCNSCLCTNBC - Triple-Negative Breast CancerCRCOvarian CancerNon-small Cell Lung CancerAdvanced Solid TumorHIV-1-infection
Gilead Sciences is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Advanced Solid Tumors, HNSCC, SCLC, NSCLC.
The trial portfolio spans Phase 1, Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Gilead Sciences
How many clinical trials has Gilead Sciences sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Gilead Sciences, of which 6 are actively recruiting participants. These trials cover conditions including Advanced Solid Tumors, HNSCC, SCLC. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Gilead Sciences research focus on?
Gilead Sciences clinical trials span Advanced Solid Tumors, HNSCC, SCLC, NSCLC, TNBC - Triple-Negative Breast Cancer, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Gilead Sciences clinical trial?
To participate in a Gilead Sciences trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Gilead Sciences trials with current recruitment status updated daily.
Clinical Trials by Gilead Sciences
NCT06657222 Phase 1, Phase 2
Recruiting
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
NCT06303505 Phase 1, Phase 2
Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Ovarian Cancer
NCT07128303 Phase 1
Recruiting
Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors
Advanced Solid Tumor
NCT07645287 Phase 2
Recruiting
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
HIV-1-infection
NCT07841977 Phase 2
Recruiting
Study of Seladelpar and Cilofexor in Participants With Primary Biliary Cholangitis
Primary Biliary Cholangitis
NCT06532565 Phase 1
Recruiting
Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
Advanced Solid Tumors
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology